Cannabis Law Report

JUNE 16, 2020

New Frontier Data is proud to partner with Groff NA and Farmacy Partners to present: U.S. Hemp Market Report: Cannabinoids Edition, Volume 1. This report … Read More.

Data 59

Data Cannabinoids Hemp 59

Canna Law Blog

AUGUST 7, 2023

It seems as if there is a new cannabinoid product coming out every five minutes. Scratch that – it seems like there is a new cannabinoid coming out every five minutes. Today, every time I research these new cannabinoids, I inevitably see ones I have never heard of before. But, it can be intoxicating. ” I agree.

Cannabinoids 76

Cannabinoids Food DEA CBD 76

The Cannigma

NOVEMBER 24, 2022

Here’s how it works: Fill out the screening questionnaire to see if you’re a good fit Week 1: screening week for approved participants (baseline data) Weeks 2 – 3: Consuming the product and sharing your experience with People Science. The data collected will be sent to People Science, along with the responses from a short daily questionnaire.

Sleep 95

Sleep Collective Data Tincture 95

Veriheal

DECEMBER 15, 2021

Published in the Journal of Medical Internet Research, the fresh data suggests that the cannabinoids found in cannabis, such as THC and CBD , may have potential as a treatment for sleep deprivation. Treating Insomnia With Cannabinoids.

Sleep 98

Sleep Cannabinoids Therapy Treatment 98

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

The Cannigma

SEPTEMBER 18, 2023

So it’s not surprising that products that combine cannabis and melatonin are making their way into legal marketing – and according to real world data gathered in a recent campaign on The Cannigma, it’s a winning combination. What’s in FOCL’s DEEP SLEEP, Full Spectrum+ Gummies? So what’s in these gifted gummies?

Sleep 83

Sleep Data THC CBD 83

Veriheal

SEPTEMBER 6, 2022

Synthetic cannabis and cannabinoids have been connected to adverse effects time and time again. When it comes to synthetic or semi-synthetic cannabinoids, consumers are often unaware of the potential risks that come with consuming such forms of cannabis. Examples of these are delta-8 THC , delta-10 THC , and HHC. .

Cannabinoids 87

Cannabinoids THC CBD Blood Pressure 87

Canna Law Blog

JUNE 9, 2023

The event is titled, From Lab to Label: Safegaurding Consumers in the Cannabinoid Product Landscape. This is the third webinar in the NCIA’s 5-part series on minor, novel, and synthetic cannabinoids like CBG, CBN, THCv, and many others.

Events 72

Events Cannabinoids Compliance Compliance 72

Green Relief

MAY 7, 2021

BY NORML Analysis: Marijuana Use Data Fails to Support “Gateway Hypothesis” POSTED ON MAY 6, 2021 Boise, Idaho: Claims that the initiation of marijuana use is independently linked to the later use of other controlled substances are not supported by longitudinal data, according to a study published in the Journal of Experimental Criminology.

Data 98

Data Marijuana Chronic Pain Oil 98

Veriheal

FEBRUARY 28, 2023

Technology-enabled clinical research company People Science is carrying out a study into the effects of cannabinoids on sleep behavior. million, People Science plans to invest in ongoing R&D on cannabis, cannabinoids, the microbiome, psychedelics, and digital health interventions. The company is now sitting on $8.5

Sleep 52

Sleep Cannabinoids Food Data 52

The Cannigma

JANUARY 16, 2021

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. EG: Right, yeah.

Data 100

Data Research and Development Patients Strains 100

Cannabis Law Report

JULY 27, 2021

.–(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoid research, has appointed Nicolas Schlienz, Ph.D., His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). About Realm of Caring.

Data 105

Data Epilepsy Research and Development Clinical Trials 105

Medicinal Genomics

JANUARY 8, 2020

Finally, the team mapped whole-genome sequence data from a diverse set of 42 male, female, and monoecious cannabis and hemp varietals to the reference. CNV maps like the ones shown below may play an important role in breeding cannabis and hemp varieties for cannabinoids, terpenes, and pathogen resistance. Cannabinoid synthase genes.

Cannabinoids 98

Cannabinoids Data Terpenes Medicine 98

Medicinal Genomics

JULY 9, 2020

We added new data visualizations and a variant table that displays Amino Acid changing SNPS in the THCA, CBDA, and CBCA synthase genes. After all, studies have shown that when THCA, CBCA, and CBDA are cloned into yeast, fed precursor, and subjected to certain conditions, they can create different cannabinoids.

Data 59

Data Cannabinoids Conditions Hemp 59

The Cannigma

NOVEMBER 23, 2021

Listen & Subscribe: Finding the correct dosage and combination of cannabinoid products for medical treatment is almost universally a long and expensive process of trial and error. The app helps patients make sense of their journey by simplifying the information and supplying data-driven insights into their regimen and its effects.

Data 52

Data Patients Access Wellness and Beauty 52

Cannabis Law Report

NOVEMBER 2, 2021

The plan follows two reports to Congress last year (which the Perkins Coie Cannabis Industry Group has previously written about here and here ) on the safety and labeling of products containing cannabidiol (CBD) and a public statement from outgoing FDA leadership in early 2021 seeking better data for a better understanding of CBD safety.

Safety 52

Safety Data Supply Chain Research and Development 52

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events.

Safety 52

Safety Cannabinoids Events Data 52

Project CBD

JUNE 20, 2023

The endocannabinoid system is widely distributed throughout the gastrointestinal system, including not only CB1 and CB2 cannabinoid receptors but also other cannabinoid targets like PPARs, GPR55, and TRPV1. Even small doses of cannabis can soothe the stomach and stimulate the appetite.

Cannabinoids 208

Cannabinoids Patients Treatment Conditions 208

Cannabis Law Report

AUGUST 23, 2021

Oxford Cannabinoid Technologies Holdings plc. After confirmation of 6-months stability of tech-transfer batch, the work has been initiated, with preliminary data packages available by the second half of September, well within the proposed timelines. Pre-Close Trading Update; US OTC QB Market Application. &

Cannabinoids 98

Cannabinoids Research and Development Clinical Trials Packaging 98

NORML

MARCH 30, 2020

There is an absence of clinical data supporting the efficacy of CBD as an antiviral agent, according to a systematic literature review published in the journal Cannabis and Cannabinoid Research. However, this data was based solely on preclinical findings.

CBD 293

CBD Clinical Trials Data Treatment 293

The Cannigma

NOVEMBER 1, 2023

Despite being touted as a wonder drug, CBD doesn’t work for everyone, and many clinicians are now leaning into other cannabinoids. And along with research, real-world data can help us understand how topical products infused with minor cannabinoids could help with various aches and pains.

Topical 82

Topical Data Terpenes Cannabinoids 82

NORML

APRIL 30, 2020

The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management.

Chronic Pain 341

Chronic Pain Clinical Trials Data Patients 341

Cannabis Law Report

JANUARY 20, 2022

The Oregon Liquor Control Commission (OLCC) recently finalized new administrative rules on Delta-8 THC and other artificially derived cannabinoids as directed by HB 3000 (2021). Delta-8 THC and other Artificially Derived Cannabinoids. Artificially Derived Cannabinoids Allowed in SOME Situations.

Cannabinoids 52

Cannabinoids THC Food Hemp 52

Project CBD

AUGUST 9, 2023

I counted over 175 talks and posters at the 33rd annual gathering of the International Cannabinoid Research Society (ICRS), which convened in Toronto at the end of June. In accordance with longstanding ICRS policy, all speakers presented new findings and data that had not yet been published in a peer-reviewed journal.

Cannabinoids 180

Cannabinoids THC CBD Blood Pressure 180

Cannabis Law Report

NOVEMBER 12, 2021

Neil Mahapatra is a co-founder of the Oxford Cannabinoid Technologies (OCT) which floated on the LSE in the May this year, he is also founder of UK venture capital business Kingsley Capital Partners (KCP). Oxford Cannabinoid Technologies’ Shares Fall A Further 20% As Chairman Stands Down Following Market Rule Breach.

Cannabinoids 98

Cannabinoids Clinical Trials Research and Development Pharmaceutical 98

Cannabis Law Report

DECEMBER 4, 2019

Based on her data, Dr. Snyder finds that requiring “Total THC” concentrations not to exceed 0.3%, rather than just limiting ?9-THC, 9-THC is commonly referred to simply as THC and is the cannabinoid known for its psychoactive effects. THCA is a non-psychoactive cannabinoid found in higher concentrations in cannabis plants.

Data 59

Data THC Strains Concentrates 59

Cannabis Law Report

OCTOBER 14, 2021

On September 30, 2021, the Oregon Liquor and Cannabis Commission (OLCC) held its first rules advisory committee (RAC) meeting to discuss delta-8-THC and other artificially derived cannabinoids. What is an Artificially Derived Cannabinoid?

Cannabinoids 52

Cannabinoids Extraction Edibles Policy 52

Cannabis Info

JULY 12, 2019

CBD for Pets Yes the Data says it works ! It mainly consists of two types of cannabinoid receptors (CB1 and CB2). These receptors are built to interact with endocannabinoids (cannabinoids naturally produced by the brain). The endocannabinoid system is essentially the system that processes cannabinoids introduced into the body.

Pets 45

Pets Data CBD Cannabinoids 45

Project CBD

FEBRUARY 27, 2023

Across the eight studies they analyzed, the Australia-based authors identified increased levels of oleoylethanolamide and stearoylethanolamide (endocannabinoid-like molecules called N-Acylethanolamines that don’t bind with the cannabinoid receptors) in patients with these conditions compared to controls. Pain reports vol. 7,6 e1045.

THC 144

THC CBD Sleep Clinical Trials 144

Project CBD

MAY 3, 2023

Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session. You have said that cannabigerol, or CBG, is one of your favorite cannabinoids. Is that because CBG is a precursor for the other plant cannabinoids?

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Cannabis Law Report

DECEMBER 14, 2021

(“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. Food and Drug Administration (FDA) on December 1, 2021. About IGC: India Globalization Capital, Inc.

Clinical Trials 52

Clinical Trials Safety Data Patients 52

Cannabis Law Report

SEPTEMBER 22, 2021

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Cannabis Law Report

JANUARY 10, 2022

Minor Cannabinoids Market Size, Share & Trends Analysis Report by Product (CBG, CBC, CBN, THCV, CBGA), by Application (Pain Management, Neurological Disorders), and Segment Forecasts, 2021-2028” report has been added to ResearchAndMarkets.com’s offering. minor cannabinoids market size is expected to reach USD 26.2

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

Veriheal

NOVEMBER 21, 2023

Quemarr Moatamedi School: University of Montana Major/Program: Linguistics and Anthropology Innovation: Emulsion-Based Edibles: Harnessing Anti-Diabetic Cannabinoids in Diabetes Management. Quemarr presents an emulsion-based drug delivery system tailored for cannabinoids and made to tackle America’s diabetes crisis.

Research and Development 106

Research and Development Consumption Education Data 106

Cannabis Law Report

JANUARY 3, 2022

(Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, announces that the first patient has been dosed in a Phase 2 proof-of-concept clinical study investigating ANEB-001 as a potential treatment for acute cannabinoid intoxication.

Pharmaceutical 52

Pharmaceutical Cannabinoids Treatment Clinical Trials 52

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45